Prototypical imidazoline-1 receptor ligand moxonidine activates alpha2- adrenoceptors in bulbospinal neurons of the RVL

Journal of Neurophysiology

Volumn 83, Issue 2, 2000, Pages 766-776

  Hayar, Abdallah ^a,b   Guyenet, Patrice G ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 1H 3 BENZAZEPINE; ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; IMIDAZOLINE DERIVATIVE; IMIDAZOLINE I1 RECEPTOR; LIGAND; MOXONIDINE; PRAZOSIN;

ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD VESSEL TONE; CONTROLLED STUDY; DRUG MECHANISM; DRUG RECEPTOR BINDING; EXCITATORY POSTSYNAPTIC POTENTIAL; HYPERTENSION; MEDULLA OBLONGATA; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD NERVE CELL; SYMPATHETIC NERVE CELL;

EID: 0033954007     PISSN: 00223077     EISSN: None     Source Type: Journal    
DOI: 10.1152/jn.2000.83.2.766     Document Type: Article

References (43)

1. ALLEN, A. M. AND GUYENET, P. G. Alpha2-adrenoceptor-mediated inhibition of bulbospinal barosensitive cells of rat rostral medulla. Am. J. Physiol. 265 (Regulatory Integrative Comp. Physiol. 34): R1065-R1075, 1993.
2. ARMAH, B. I., HOFFERBER, E., AND STENZEL, W. General pharmacology of the novel centrally acting antihypertensive agent moxonidine. Arzneimittelforschung 38: 1426-1434, 1988.
3. BERTOLINO, M., VICINI, S., GILLIS, R., AND TRAVAGLI, A. Presynaptic alpha2-adrenoceptors inhibit excitatory synaptic transmission in rat brain stem. Am. J. Physiol. 272 (Gastrointest. Liver Physiol. 35): G654-G661, 1997.
4. CHAN, C. K. AND HEAD, G. A. Relative importance of central imidazoline receptors for the antihypertensive effects of moxonidine and rilmenidine. J. Hypertens. 14: 855-864, 1996.
5. ERNSBERGER, P., GIULIANO, R., WILLETTE, R. N., AND REIS, D. J. Role of imidazole receptors in the vasodepressor response to clonidine analogs in the rostral ventrolateral medulla. J. Pharmacol. Exp. Ther. 253: 408-418, 1990.
6. ERNSBERGER, P. AND HAXHIU, M. A. The I1-imidazoline-binding site is a functional receptor mediating vasodepression via the ventral medulla. Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R1572-R1579, 1997.
7. GAISER, E. G., TRENDELENBURG, A. U., AND STARKE, K. A search for presynaptic imidazoline receptors at rabbit and rat noradrenergic neurones in the absence of alpha 2-autoinhibition. Naunyn Schmiedebergs Arch. Pharmacol. 359: 123-132, 1999.
8. GUYENET, P. G. Is the hypotensive effect of clonidine and related drugs due to imidazoline binding sites? Am. J. Physiol. 273 (Regulatory Integrative Comp. Physiol. 42): R1580-R1584, 1997.
9. GUYENET, P. G., KOSHIYA, N., HUANGFU, D., BARABAN, S. C., STORNETTA, R. L., AND LI, Y. W. Role of medulla oblongata in generation of sympathetic and vagal outflows. Prog. Brain Res. 107: 127-144, 1996.
10. GUYENET, P. G., STORNETTA, R. L., RILEY, T., NORTON, F. R., ROSIN, D. L., AND LYNCH, K. R. Alpha 2A-adrenergic receptors are present in lower brainstem catecholaminergic and serotonergic neurons innervating spinal cord. Brain Res. 638: 285-294, 1994.
11. HAYAR, A., FELTZ, P., AND PIGUET, P. Adrenergic responses in silent and putative inhibitory pacemaker-like neurons of the rat rostral ventrolateral medulla in vitro. Neuroscience 77: 199-217, 1997.
12. HAYAR, A. AND GUYENET, P. Pre-and postsynaptic inhibitory actions of methionine-enkephalin on identified bulbospinal neurons of the rat rostral ventrolateral medulla. J. Neurophysiol. 80: 2003-2014, 1998.
13. HAYAR, A. AND GUYENET, P. Alpha2-adrenoceptor-mediated presynaptic inhibition in bulbospinal neurons of the rostral ventrolateral medulla. Am. J. Physiol. 277 (Heart Circ. Physiol. 46): H1060-H1080, 1999.
14. HEAD, G. A. Central monoamine systems and new antihypertensive agents. Clin. Exp. Hypertens. 17: 141-152, 1995.
15. HEAD, G. A., BURKE, S. L., AND CHAN, C. K. Central imidazoline receptors and centrally acting anti-hypertensive agents. Clin. Exp. Hypertens. 19: 591-605, 1997.
16. HEAD, G. A., CHAN, C. K., AND BURKE, S. L. Relationship between imidazoline and alpha2-adrenoceptors involved in the sympatho-inhibitory actions of centrally acting antihypertensive agents. J. Auton. Nerv. Syst. 72: 163-169, 1998.
17. HIEBLE, J. P., DEMARINIS, R. M., FOWLER. P. J., AND MATTHEWS, W. D. Selective alpha-2 adrenoceptor blockade by SK&F 86466: in vitro characterization of receptor selectivity. J. Pharmacol. Exp. Ther. 236: 90-96, 1986.
18. KANGRGA, I. M. AND LOEWY, A. D. Whole-cell recordings from visualized C1 adrenergic bulbospinal neurons: ionic mechanisms underlying vasomotor tone. Brain Res. 670: 215-232, 1995.
19. Li, Y. W., BAYLISS, D. A., AND GUYENET, P. G. C1 neurons of neonatal rats: intrinsic beating properties and alpha 2-adrenergic receptors. Am. J. Physiol. 269 (Regulatory Integrative Comp. Physiol. 38): R1356-R1369, 1995.
20. Li, Y. W., GUYENET, P. G., AND BAYLISS, D. A. Voltage-dependent calcium currents in bulbospinal neurons of neonatal rat rostral ventrolateral medulla: modulation by alpha2-adrenergic receptors. J. Neurophysiol. 79: 583-594, 1998.
21. LINK, R. E., DESAI, K., HEIN, L., STEVENS, M. E., CHRUSCINSKI, A., BERNSTEIN, D., BARSH, G. S., AND KOBILKA, B. K. Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. Science 273: 803-805, 1996.
22. MACMILLAN, L. B., HEIN, L., SMITH, M. S., PIASCIK, M. T., AND LIMBIRD, L. E. Central hypotensive effects of the alpha2a-adrenergic receptor subtype. Science 273: 801-803, 1996.
23. MCALLEN, R. M., MAY, C. N., AND CAMPOS, R. R. The supply of vasomotor drive to individual classes of sympathetic neuron. Clin. Exp. Hypertens. 19: 607-618, 1997.
24. A receptors. Neuropharmacology 26: 779-783, 1987.
25. MILNER, T. A., ROSIN, D. L., LEE, A., AND AICHER, S. A. Alpha2A-adrenergic receptors are primarily presynaptic heteroreceptors in the C1 area of the rat rostral ventrolateral medulla. Brain Res. 821: 200-211, 1999.
26. MUNK, S. A., LAI, R. K., BURKE, J. E., ARASASINOHAM, P. N., KHARLAMB, A. B., MANLAPAZ, C. A., PADILLO, E. U., WIJONO, M. K., HASSON, D. W., WHEELER, L. A., AND GARST, M. E. Synthesis and pharmacologie evaluation of 2-endo-amino-3-exo-isopropylbicyclo[2.2.1]heptane: a potent imidazolinel receptor specific agent. J. Med. Chem. 39: 1193-1195, 1996.
27. h) in rat hypoglossal motoneurons. Brain Res. 769: 108-118, 1997.
28. PRICHARD, B. N., OWENS, C. W., AND GRAHAM, B. R. Pharmacology and clinical use of moxonidine, a new centrally acting sympatholytic antihypertensive agent. J. Hum. Hypertens. 11: S29-S45, 1997.
29. PUNNEN, S., URBANSKI, R., KRIEGER, A. J., AND SAPRU, H. N. Ventrolateral medullary pressor area: site of hypotensive action of clonidine. Brain Res. 422: 336-346, 1987.
30. REIS, D. J. Neurons and receptors in the rostroventrolateral medulla mediating the antihypertensive actions of drugs acting at imidazoline receptors. J. Cardiovasc. Pharmacol. 27: S11-S18, 1996.
31. Ross, C. A., RUGGIERO, D. A., JOH, T. H., PARK, D. H., AND REIS, D. J. Rostral ventrolateral medulla: selective projections to the thoracic autonomic cell column from the region containing C1 adrenaline neurons. J. Comp. Neurol. 228: 168-185, 1984.
32. RUGGIERO, D. A., CRAVO, S. L., GOLANOV, E., GOMEZ, R., ANWAR, M., AND REIS, D. J. Adrenergic and non-adrenergic spinal projections of a cardiovascular-active pressor area of medulla oblongata: quantitative topographic analysis. Brain Res. 663: 107-120, 1994.
33. SCHAFER, S. G., KAAN, E. C., CHRISTEN, M. O., LOW-KROGER, A., MEST, H. J., AND MOLDERINGS, G. J. Why imidazoline receptor modulator in the treatment of hypertension? Ann. NY Acad. Sci. 763: 659-672, 1995.
34. SCHLICKER, E., ARMAH, B. I., AND GOTHERT, M. Central presynaptic alpha 2-autoreceptors are involved in the blood pressure-lowering effect of moxonidine. J. Cardiovasc. Pharmacol. 16: 15-22, 1990.
35. SESOKO, S., MURATANI, H., YAMAZATO, M., TERUYA, H., TAKISHITA, S., AND FUKIYAMA, K. Contribution of alpha 2-adrenoceptors in caudal ventrolateral medulla to cardiovascular regulation in rat. Am. J. Physiol. 274 (Regulatory Integrative Comp. Physiol. 43): R1119-R1124, 1998.
36. SUN, M. K. Central neural organization and control of sympathetic nervous system in mammals. Prog. Neurobiol. 47: 157-233, 1995.
37. SZABO, B., FROHLICH, R., AND ILLES, P. No evidence for functional imidazoline receptors on locus coeruleus neurons. Naunyn Schmiedebergs Arch. Pharmacol. 353: 557-563, 1996.
38. SZABO, B. AND URBAN, R. Mechanism of sympathoinhibition by imidazolines. Ann. NY Acad. Sci. 763: 552-565, 1995.
39. TRAVAGLI, R. A. AND WILLIAMS, J. T. Endogenous monoamines inhibit glutamate transmission in the spinal trigeminal nucleus of the guinea-pig. J. Physiol. (Lond.) 491: 177-185, 1996.
40. TUCKER, D. C., SAFER, C. B., RUGGIERO, D. A., AND REIS, D. J. Organization of central adrenergic pathways. I. Relationships of ventrolateral medullary projections to the hypothalamus and spinal cord. J. Comp. Neurol. 259: 591-603, 1987.
41. WATSON, R. E., JR., WIEGAND, S. J., CLOUGH, R. W., AND HUFFMAN, G. E. Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 7: 155-159, 1986.
42. ZHU, Q. M., LESNICK, J. D., JASPER, J. R., MACLENNAN, S. J., DILLON, M. P., EGLEN, R. M., AND BLUE, D. R., JR. Cardiovascular effects of rilmenidine, moxonidine and clonidine in conscious wild-type and D79N alpha2A-adrenoceptor transgenic mice. Br. J. Pharmacol. 126: 1522-1530, 1999.
43. ZIEGLER, D., HAXHIU, M. A., KAAN, E. C., PAPP, J. G., AND ERNSBERGER, P. Pharmacology of moxonidine, an I1-imidazoline receptor agonist. J. Cardiovasc. Pharmacol. 27: S26-S37, 1996.